• bitcoinBitcoin(BTC)$64,534.00-1.39%
  • ethereumEthereum(ETH)$1,805.45-1.19%
  • tetherTether(USDT)$1.00-0.02%
  • binancecoinBNB(BNB)$590.39-1.14%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.95-1.18%
  • solanaSolana(SOL)$71.27-0.83%
  • tronTRON(TRX)$0.302612-1.79%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.060.00%
  • HyperliquidHyperliquid(HYPE)$67.27-0.92%
  • zcashZcash(ZEC)$890.92-1.90%
  • moneroMonero(XMR)$491.04-1.71%
  • dogecoinDogecoin(DOGE)$0.058538-0.62%
  • leo-tokenLEO Token(LEO)$9.201.23%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$62.48-1.29%
  • chainlinkChainlink(LINK)$9.13-1.24%
  • cardanoCardano(ADA)$0.152042-1.40%
  • RainRain(RAIN)$0.00714895.23%
  • stellarStellar(XLM)$0.137614-0.96%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • daiDai(DAI)$1.000.04%
  • nearNEAR Protocol(NEAR)$3.180.48%
  • bitcoin-cashBitcoin Cash(BCH)$206.13-1.08%
  • litecoinLitecoin(LTC)$44.53-2.45%
  • CantonCanton(CC)$0.0837294.02%
  • avalanche-2Avalanche(AVAX)$7.11-2.31%
  • uniswapUniswap(UNI)$5.140.57%
  • tether-goldTether Gold(XAUT)$3,844.310.54%
  • USD1USD1(USD1)$1.000.08%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.05-1.28%
  • suiSui(SUI)$0.72-1.01%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.057920-0.89%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.15%
  • shiba-inuShiba Inu(SHIB)$0.000004-1.46%
  • quant-networkQuant(QNT)$155.462.34%
  • BittensorBittensor(TAO)$189.35-1.30%
  • crypto-com-chainCronos(CRO)$0.042683-3.00%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.11%
  • MemeCoreMemeCore(M)$0.82-0.64%
  • okbOKB(OKB)$84.97-3.52%
  • pax-goldPAX Gold(PAXG)$3,846.660.51%
  • aaveAave(AAVE)$109.372.41%
  • Falcon USDFalcon USD(USDF)$1.000.03%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • United StablesUnited Stables(U)$1.00-0.03%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

MISATO: A Machine Learning Dataset of Protein-Ligand Complexes for Structure-based Drug Discovery

May 13, 2024
in AI & Technology
Reading Time: 4 mins read
A A
MISATO: A Machine Learning Dataset of Protein-Ligand Complexes for Structure-based Drug Discovery
ShareShareShareShareShare

In the dynamic field of AI technology, a pressing challenge for the drug discovery (DD) community, especially in structural biology and computational chemistry, is the creation of innovative models finely tuned for drug design. The core challenge lies in accurately and efficiently predicting molecular properties crucial for understanding protein-ligand interactions and optimizing binding affinities, essential for advancing effective drug development initiatives.

In current structural biology and drug design, researchers commonly depend on existing datasets and methods, which have inherent limitations like structural inaccuracies, crystallographic artifacts, and difficulties in accurately capturing the dynamic nature of protein-ligand interactions. Traditional approaches for predicting molecular properties often lack the necessary detail for complex protein-ligand interactions, neglecting the vital role of dynamics and flexibility in understanding binding mechanisms and affinity.

Researchers from the Institute of Structural Biology, Technical University of Munich, Jülich Supercomputing Centre, Helmholtz AI, Cambridge University, Jagiellonian University, and Institute of Computational Biology propose MISATO, marking a transformative shift in drug discovery and structural biology methodologies. MISATO addresses the limitations of existing methods by integrating quantum-chemically refined ligand data, molecular dynamics (MD) simulations, and advanced AI models. This comprehensive approach facilitates a nuanced understanding of molecular properties, capturing electronic structure details and dynamic behavior crucial for accurate predictions. 

MISATO takes a comprehensive approach, utilizing semi-empirical quantum chemical methods to refine ligand datasets. This method captures electronic properties with high accuracy, while also analyzing both electronic structure details and dynamic behavior, crucial for precise predictions. Additionally, classical MD simulations within MISATO characterize the dynamic behavior and conformational landscape of protein-ligand complexes, offering insights into binding mechanisms and flexibility. AI models integrated into MISATO, such as graph neural networks (GNNs), are trained on this enriched dataset to predict properties like adaptability, binding affinities, and thermodynamic parameters. Extensive experimental validations confirm the efficacy of these models in accurately predicting key molecular properties crucial for drug discovery.

In conclusion, MISATO signifies a key stride in AI-driven drug discovery and structural biology. By integrating quantum chemistry, MD simulations, and advanced AI models, MISATO provides a holistic and robust solution to challenges in structure-based drug design, enhancing accuracy and efficiency and empowering researchers with potent tools.


Check out the Paper. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter. Join our Telegram Channel, Discord Channel, and LinkedIn Group.

If you like our work, you will love our newsletter..

Don’t Forget to join our 42k+ ML SubReddit


YOU MAY ALSO LIKE

Moth’s Tessa Encodes and Recovers 1,568 Values on a 120-Qubit Chip – Unite.AI

Flagship Pioneering Launches London Lab to Build AI-Native Companies – Unite.AI

Aswin AK is a consulting intern at MarkTechPost. He is pursuing his Dual Degree at the Indian Institute of Technology, Kharagpur. He is passionate about data science and machine learning, bringing a strong academic background and hands-on experience in solving real-life cross-domain challenges.


[Recommended Read] Rightsify’s GCX: Your Go-To Source for High-Quality, Ethically Sourced, Copyright-Cleared AI Music Training Datasets with Rich Metadata


Credit: Source link

ShareTweetSendSharePin

Related Posts

Moth’s Tessa Encodes and Recovers 1,568 Values on a 120-Qubit Chip – Unite.AI
AI & Technology

Moth’s Tessa Encodes and Recovers 1,568 Values on a 120-Qubit Chip – Unite.AI

November 16, 2026
Flagship Pioneering Launches London Lab to Build AI-Native Companies – Unite.AI
AI & Technology

Flagship Pioneering Launches London Lab to Build AI-Native Companies – Unite.AI

November 16, 2026
Apple’s New Research App Is Designed To Make AI Health Tools More User-Friendly
AI & Technology

Apple’s New Research App Is Designed To Make AI Health Tools More User-Friendly

November 16, 2026
APA Issues Workplace AI Guidance on Trust, Oversight and Job Design – Unite.AI
AI & Technology

APA Issues Workplace AI Guidance on Trust, Oversight and Job Design – Unite.AI

November 16, 2026
Next Post
Video shows aftermath of U.S. drone strike that killed militant commander

Video shows aftermath of U.S. drone strike that killed militant commander

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Ossoff thanks supporters after re-election win in Georgia

Ossoff thanks supporters after re-election win in Georgia

November 11, 2026
The Fed Just Made A Move… Are You Ready?

The Fed Just Made A Move… Are You Ready?

November 12, 2026
Live Updates: Trump says there is "no reason" to escalate war with Iran, touts his long-term goals in the conflict – CBS News

Live Updates: Trump says there is "no reason" to escalate war with Iran, touts his long-term goals in the conflict – CBS News

November 9, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!